Literature DB >> 9144379

In vivo semen-associated pH neutralization of cervicovaginal secretions.

C Tevi-Bénissan1, L Bélec, M Lévy, V Schneider-Fauveau, A Si Mohamed, M C Hallouin, M Matta, G Grésenguet.   

Abstract

Physiological cervicovaginal acidity can partly inactivate human immunodeficiency virus (HIV). Basic semen components should be able to partially neutralize in vivo cervicovaginal pH. The goals of the study were to evaluate the relationship between cervicovaginal pH and presence of semen components in sexually active African women and to assess whether vaginal douching with water performed just after sexual intercourse could significantly reduce semen components and restore physiological cervicovaginal pH. Cervicovaginal secretion (CVS) from 56 heterosexual African women (19 to 45 years old), living in Bangui, Central African Republic, were evaluated for pH, semen components (prostatic acid phosphatase [PAP] and prostatic specific antigen [PSA]), cellularity, and hemoglobin at inclusion and after vaginal douching with 100 ml of water by using a bock. Before douching, semen components were found in 46 of 56 CVS (82%). The mean vaginal pH was 5.2 (range, 3.6 to 7.7), and concentrations of both PAP and PSA correlated positively and strongly with cervicovaginal pH (P < 0.001). After douching, semen components were found in 35 of 56 CVS (62%) (P = 0.03). Cervicovaginal PAP and PSA levels were significantly decreased (respectively, P < 0.0001 and P < 0.01; PAP, -72%; PSA, -87%), as was the total cell count (-60%; P < 0.0001). Furthermore, in CVS previously positive for both PAP and PSA, the mean vaginal pH was significantly decreased (6.5 versus 5.3, P < 0.01); no genital bleeding was observed. Frequent persistence of semen in CVS from heterosexually active African women leads to a shift from acidity to neutrality that could favor male to female HIV transmission. Vaginal douching provides significant elimination of semen after sexual intercourse; it should be considered for study as a supplementary means for the prevention of heterosexual HIV transmission.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9144379      PMCID: PMC170534          DOI: 10.1128/cdli.4.3.367-374.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications.

Authors:  J Ongradi; L Ceccherini-Nelli; M Pistello; S Specter; M Bendinelli
Journal:  AIDS Res Hum Retroviruses       Date:  1990-12       Impact factor: 2.205

2.  Risk factors for HIV among prostitutes in Chiangmai, Thailand.

Authors:  T Siraprapasiri; S Thanprasertsuk; A Rodklay; S Srivanichakorn; P Sawanpanyalert; J Temtanarak
Journal:  AIDS       Date:  1991-05       Impact factor: 4.177

3.  The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro.

Authors:  T J O'Connor; D Kinchington; H O Kangro; D J Jeffries
Journal:  Int J STD AIDS       Date:  1995 Jul-Aug       Impact factor: 1.359

4.  Continuous measurement by radio-telemetry of vaginal pH during human coitus.

Authors:  C A Fox; S J Meldrum; B W Watson
Journal:  J Reprod Fertil       Date:  1973-04

5.  The forensic laboratory evaluation of evidence in alleged rape.

Authors:  M R Soules; A A Pollard; K M Brown; M Verma
Journal:  Am J Obstet Gynecol       Date:  1978-01-15       Impact factor: 8.661

6.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

7.  HIV infection and vaginal douching in central Africa.

Authors:  G Gresenguet; J K Kreiss; M K Chapko; S L Hillier; N S Weiss
Journal:  AIDS       Date:  1997-01       Impact factor: 4.177

8.  Delineation between T and B suppressive molecules from human seminal plasma: II. Spermine is the major suppressor of T-lymphocytes in vitro.

Authors:  C P Quan; C Roux; J Pillot; J P Bouvet
Journal:  Am J Reprod Immunol       Date:  1990 Jan-Feb       Impact factor: 3.886

9.  Detection of seminal antibodies to human immunodeficiency virus in vaginal secretions after sexual intercourse: possible means of preventing the risk of human immunodeficiency virus transmission in a rape victim.

Authors:  L Bélec; M Matta; C Payan; C Tévi-Bénissan; D Meillet; J Pillot
Journal:  J Med Virol       Date:  1995-01       Impact factor: 2.327

10.  Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays.

Authors:  L Bélec; D Meillet; M Lévy; A Georges; C Tévi-Bénissan; J Pillot
Journal:  Clin Diagn Lab Immunol       Date:  1995-01
View more
  47 in total

1.  Histidine-Rich Glycoprotein Inhibits HIV-1 Infection in a pH-Dependent Manner.

Authors:  Juan Sabatté; Jorge Geffner; Ezequiel Dantas; Fernando Erra Díaz; Pehuén Pereyra Gerber; Augusto Varese; Diana Alicia Jerusalinsky; Alberto L Epstein; Hernán J García Rivello; Ana Del Valle Jaén; Julieta B Pandolfi; Ana Ceballos; Matias Ostrowski
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 2.  Vaginal douching: evidence for risks or benefits to women's health.

Authors:  Jenny L Martino; Sten H Vermund
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

3.  Digallate dimers of (-)-epigallocatechin gallate inactivate herpes simplex virus.

Authors:  Charles E Isaacs; Weimin Xu; George Merz; Sharon Hillier; Lisa Rohan; Guang Y Wen
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

4.  Diverse nitrogen sources in seminal fluid act in synergy to induce filamentous growth of Candida albicans.

Authors:  Francisco J Alvarez; Kicki Ryman; Cornelis Hooijmaijers; Vincent Bulone; Per O Ljungdahl
Journal:  Appl Environ Microbiol       Date:  2015-02-06       Impact factor: 4.792

5.  Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion.

Authors:  Jeffrey R Brender; Kevin Hartman; Lindsey M Gottler; Marchello E Cavitt; Daniel W Youngstrom; Ayyalusamy Ramamoorthy
Journal:  Biophys J       Date:  2009-11-04       Impact factor: 4.033

6.  Predicting first traversal times for virions and nanoparticles in mucus with slowed diffusion.

Authors:  Austen M Erickson; Bruce I Henry; John M Murray; Per Johan Klasse; Christopher N Angstmann
Journal:  Biophys J       Date:  2015-07-07       Impact factor: 4.033

7.  Site specific interaction of the polyphenol EGCG with the SEVI amyloid precursor peptide PAP(248-286).

Authors:  Nataliya Popovych; Jeffrey R Brender; Ronald Soong; Subramanian Vivekanandan; Kevin Hartman; Venkatesha Basrur; Peter M Macdonald; Ayyalusamy Ramamoorthy
Journal:  J Phys Chem B       Date:  2012-03-07       Impact factor: 2.991

8.  Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.

Authors:  M C Skinner; A O Kiselev; C E Isaacs; T A Mietzner; R C Montelaro; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

9.  Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.

Authors:  Mimi Ghosh; John V Fahey; Zheng Shen; Timothy Lahey; Susan Cu-Uvin; Zhijin Wu; Kenneth Mayer; Peter F Wright; John C Kappes; Christina Ochsenbauer; Charles R Wira
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

10.  Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI.

Authors:  Kyeong-Ae Kim; Maral Yolamanova; Onofrio Zirafi; Nadia R Roan; Ludger Staendker; Wolf-Georg Forssmann; Adam Burgener; Nathalie Dejucq-Rainsford; Beatrice H Hahn; George M Shaw; Warner C Greene; Frank Kirchhoff; Jan Münch
Journal:  Retrovirology       Date:  2010-06-23       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.